Showing results (721-730 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|December 28, 2016
Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growthSagar Shelake, Umesh T Sankpal, W Paul Bowman, et al.
Investigational New Drugs|October 27, 2016
Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trialsEmilie Boissier, Olivier Mir, Antoine Hollebecque, et al.
Investigational New Drugs|January 6, 2017
A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumorsHirofumi Mukai, Takahiro Kogawa, Nobuaki Matsubara, et al.
Investigational New Drugs|January 11, 2017
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumorsGeoffrey I Shapiro, Ulka N Vaishampayan, Patricia LoRusso, et al.
Investigational New Drugs|December 3, 2016
Current achievements and future perspectives of metronomic chemotherapyAdriana Romiti, Rosa Falcone, Michela Roberto, et al.
Investigational New Drugs|February 5, 2008
Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID miceWilliam C Zamboni, Laura L Jung, Sandra Strychor, et al.
Investigational New Drugs|October 10, 2009
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell linesTiffany J Somers-Edgar, Sebastien Taurin, Lesley Larsen, et al.
Investigational New Drugs|April 10, 2014
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trialSung-Bae Kim, Changhoon Yoo, Jungsil Ro, et al.
Investigational New Drugs|March 27, 2014
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinomaAna De Jesus-Acosta, Daniel Laheru, Anirban Maitra, et al.
Investigational New Drugs|May 14, 2008
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinomaDennis L Carter, Lina Asmar, David Barrera, et al.
Pageof 372